A previous case series has suggested that the presence of JAK2 and CALR did not appear to affect the prognosis or clinical features of ET, thereby suggesting that the disease phenotype is dictated primarily by the JAK2 mutation. Here, JAK2 is linked to essential thrombocythemia.